Toll-like receptor 4 shRNA attenuates lipopolysaccharide-induced epithelial-mesenchymal transition of intrahepatic biliary epithelial cells in rats. 2018

Shifang Tang, and Xiuhan Jiang, and Lang Wu, and Shifa Chen, and Ling Chen, and Jichang Jiang, and Pengzhan Yan, and Fang Wang, and Kui Tu, and Dianbei Wang, and Jin Gu, and Lijin Zhao
Department of Hepatobiliary Surgery, Affiliated Hospital of Zunyi Medical College, Zunyi, 563000, Guizhou, China.

OBJECTIVE Intrahepatic biliary epithelial cells (IBECs) of the bile duct in liver tissue of patients with hepatolithiasis promoted the development of diseases through epithelial-mesenchymal transition (EMT). This study investigated whether lipopolysaccharide (LPS), a cell-wall constituent of gram-negative bacteria, could induce EMT of IBECs and toll-like receptor 4 (TLR4) had a regulatory role via activating the nuclear factor-κB (NF-κB)/Snail signaling pathway during this process in vivo. METHODS TLR4 short hairpin RNA (shRNA) adenovirus or negative control shRNA (NC shRNA) adenovirus (1 × 109 plaque-forming unit (PFU), respectively) was injected into the caudal vein of rats. After 96 h, 1 mg/kg LPS was infused retrogradely into the common bile duct for 48 h per rat. The effects of TLR4 shRNA on LPS-induced EMT were determined by evaluating the histopathological changes in IBECs using hematoxylin and eosin staining and the changes in the levels of EMT markers, TLR4, NF-κB p65, pNF-κB p65, and Snail using real-time polymerase chain reaction and Western blot analysis. RESULTS Compared with normal saline treatment, a loss of epithelial cell markers (E-cadherin and cytokeratin 7) and a gain of mesenchymal cell markers (N-cadherin and matrix metalloproteinase 2) were revealed. The levels of TLR4, NF-κB phosphorylation, and Snail significantly increased after LPS treatment, whereas pretreatment with TLR4 shRNA inhibited the LPS-induced EMT by downregulating the NF-κB/Snail signaling pathway. CONCLUSIONS LPS induced the EMT of IBECs by activating TLR4. The RNAi-mediated knockdown of TLR4 suppressed EMT occurrence via downregulating the NF-κB/Snail signaling pathway, implicating TLR4 as a new target for human hepatolithiasis.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008297 Male Males
D004847 Epithelial Cells Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional epithelial cells. Adenomatous Epithelial Cells,Columnar Glandular Epithelial Cells,Cuboidal Glandular Epithelial Cells,Glandular Epithelial Cells,Squamous Cells,Squamous Epithelial Cells,Transitional Epithelial Cells,Adenomatous Epithelial Cell,Cell, Adenomatous Epithelial,Cell, Epithelial,Cell, Glandular Epithelial,Cell, Squamous,Cell, Squamous Epithelial,Cell, Transitional Epithelial,Cells, Adenomatous Epithelial,Cells, Epithelial,Cells, Glandular Epithelial,Cells, Squamous,Cells, Squamous Epithelial,Cells, Transitional Epithelial,Epithelial Cell,Epithelial Cell, Adenomatous,Epithelial Cell, Glandular,Epithelial Cell, Squamous,Epithelial Cell, Transitional,Epithelial Cells, Adenomatous,Epithelial Cells, Glandular,Epithelial Cells, Squamous,Epithelial Cells, Transitional,Glandular Epithelial Cell,Squamous Cell,Squamous Epithelial Cell,Transitional Epithelial Cell
D000071250 Snail Family Transcription Factors A transcription factor family characterized by the presence of several C-terminal CYS2-HIS2 ZINC FINGERS. They function in many developmental processes including the induction of the EPITHELIAL-MESENCHYMAL TRANSITION; maintenance of embryonic MESODERM; growth arrest, CELL SURVIVAL; and CELL MIGRATION. Slug Transcription Factors,Snail Transcription Factors,Transcription Factors, Slug,Transcription Factors, Snail
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001653 Bile Ducts, Intrahepatic Passages within the liver for the conveyance of bile. Includes right and left hepatic ducts even though these may join outside the liver to form the common hepatic duct. Bile Duct, Intrahepatic,Duct, Intrahepatic Bile,Ducts, Intrahepatic Bile,Intrahepatic Bile Duct,Intrahepatic Bile Ducts
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015536 Down-Regulation A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Down-Regulation,Down-Regulation (Physiology),Downregulation,Down Regulation,Down-Regulation, Receptor
D016328 NF-kappa B Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA. Immunoglobulin Enhancer-Binding Protein,NF-kappa B Complex,Nuclear Factor kappa B,Transcription Factor NF-kB,kappa B Enhancer Binding Protein,Ig-EBP-1,NF-kB,NF-kappaB,Nuclear Factor-Kappab,Complex, NF-kappa B,Enhancer-Binding Protein, Immunoglobulin,Factor NF-kB, Transcription,Factor-Kappab, Nuclear,Ig EBP 1,Immunoglobulin Enhancer Binding Protein,NF kB,NF kappa B Complex,NF kappaB,NF-kB, Transcription Factor,Nuclear Factor Kappab,Transcription Factor NF kB

Related Publications

Shifang Tang, and Xiuhan Jiang, and Lang Wu, and Shifa Chen, and Ling Chen, and Jichang Jiang, and Pengzhan Yan, and Fang Wang, and Kui Tu, and Dianbei Wang, and Jin Gu, and Lijin Zhao
August 2012, BMC medicine,
Shifang Tang, and Xiuhan Jiang, and Lang Wu, and Shifa Chen, and Ling Chen, and Jichang Jiang, and Pengzhan Yan, and Fang Wang, and Kui Tu, and Dianbei Wang, and Jin Gu, and Lijin Zhao
December 2011, The Journal of surgical research,
Shifang Tang, and Xiuhan Jiang, and Lang Wu, and Shifa Chen, and Ling Chen, and Jichang Jiang, and Pengzhan Yan, and Fang Wang, and Kui Tu, and Dianbei Wang, and Jin Gu, and Lijin Zhao
June 2016, Journal of gastroenterology and hepatology,
Shifang Tang, and Xiuhan Jiang, and Lang Wu, and Shifa Chen, and Ling Chen, and Jichang Jiang, and Pengzhan Yan, and Fang Wang, and Kui Tu, and Dianbei Wang, and Jin Gu, and Lijin Zhao
October 2007, Chinese medical journal,
Shifang Tang, and Xiuhan Jiang, and Lang Wu, and Shifa Chen, and Ling Chen, and Jichang Jiang, and Pengzhan Yan, and Fang Wang, and Kui Tu, and Dianbei Wang, and Jin Gu, and Lijin Zhao
December 2016, The Tohoku journal of experimental medicine,
Shifang Tang, and Xiuhan Jiang, and Lang Wu, and Shifa Chen, and Ling Chen, and Jichang Jiang, and Pengzhan Yan, and Fang Wang, and Kui Tu, and Dianbei Wang, and Jin Gu, and Lijin Zhao
February 2016, Molecular medicine reports,
Shifang Tang, and Xiuhan Jiang, and Lang Wu, and Shifa Chen, and Ling Chen, and Jichang Jiang, and Pengzhan Yan, and Fang Wang, and Kui Tu, and Dianbei Wang, and Jin Gu, and Lijin Zhao
January 2021, Journal of cellular and molecular medicine,
Shifang Tang, and Xiuhan Jiang, and Lang Wu, and Shifa Chen, and Ling Chen, and Jichang Jiang, and Pengzhan Yan, and Fang Wang, and Kui Tu, and Dianbei Wang, and Jin Gu, and Lijin Zhao
October 2003, The Journal of experimental medicine,
Shifang Tang, and Xiuhan Jiang, and Lang Wu, and Shifa Chen, and Ling Chen, and Jichang Jiang, and Pengzhan Yan, and Fang Wang, and Kui Tu, and Dianbei Wang, and Jin Gu, and Lijin Zhao
January 2013, PloS one,
Shifang Tang, and Xiuhan Jiang, and Lang Wu, and Shifa Chen, and Ling Chen, and Jichang Jiang, and Pengzhan Yan, and Fang Wang, and Kui Tu, and Dianbei Wang, and Jin Gu, and Lijin Zhao
January 2013, Veterinary immunology and immunopathology,
Copied contents to your clipboard!